Published in Medical Letter on the CDC and FDA, May 30th, 2010
"Additionally, the local toxicity profile of the WIV formulations was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.